Success Metrics

Clinical Success Rate
80.0%

Based on 4 completed trials

Completion Rate
80%(4/5)
Active Trials
2(18%)
Results Posted
0%(0 trials)
Terminated
1(9%)

Phase Distribution

Ph not_applicable
2
18%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution2 total trials
N/ANon-phased studies
2(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

11

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)
Other(4)

Detailed Status

Completed4
unknown4
Recruiting2
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
11
Active
2
Success Rate
80.0%
Most Advanced
N/A

Trials by Phase

N/A2 (100.0%)

Trials by Status

recruiting218%
completed436%
unknown436%
terminated19%

Recent Activity

Clinical Trials (11)

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
11